In recentyears, an inflammation-associated model of cancers has been given attention [4, 5].PPARα exerts anti-inflammation effects by repressing nuclear factor kappa B(NFκB) [55], whichinhibits inflammation signaling and subsequent cancer [4]. Here, NFKB1 is linked to cancer.